Source: State of Affairs

Terns Pharmaceuticals: Terns Pharmaceuticals Initiates the LIFT Study, a Phase 2a Clinical Trial of TERN-101 for the Treatment of NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer,... Read More

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Senthil Sundaram's photo - CEO of Terns

CEO

Senthil Sundaram

CEO Approval Rating

90/100

Terns is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and liver diseases. Read more